Claritev Price to Sales Ratio 2019-2025 | CTEV
Historical PS ratio values for Claritev (CTEV) over the last 10 years. The current P/S ratio for Claritev as of July 30, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Claritev P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-30 | 38.68 | 0.67 | |
| 2025-03-31 | 20.63 | $57.36 | 0.36 |
| 2024-12-31 | 14.78 | $57.65 | 0.26 |
| 2024-09-30 | 7.64 | $58.41 | 0.13 |
| 2024-06-30 | 15.52 | $59.16 | 0.26 |
| 2024-03-31 | 32.44 | $59.47 | 0.55 |
| 2023-12-31 | 57.60 | $59.72 | 0.96 |
| 2023-09-30 | 67.20 | $59.68 | 1.13 |
| 2023-06-30 | 84.40 | $60.31 | 1.40 |
| 2023-03-31 | 42.40 | $63.65 | 0.67 |
| 2022-12-31 | 46.00 | $67.54 | 0.68 |
| 2022-09-30 | 114.40 | $70.75 | 1.62 |
| 2022-06-30 | 219.60 | $72.76 | 3.02 |
| 2022-03-31 | 187.20 | $71.48 | 2.62 |
| 2021-12-31 | 177.20 | $68.39 | 2.59 |
| 2021-09-30 | 225.20 | $71.77 | 3.14 |
| 2021-06-30 | 380.80 | $75.62 | 5.04 |
| 2021-03-31 | 222.00 | $78.67 | 2.82 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.635B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.937B | 59.72 |
| Hims & Hers Health (HIMS) | United States | $13.490B | 140.16 |
| Doximity (DOCS) | United States | $11.213B | 51.91 |
| Tempus AI (TEM) | United States | $10.091B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.366B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.822B | 59.72 |
| Hinge Health (HNGE) | United States | $3.402B | 0.00 |
| Privia Health (PRVA) | United States | $2.375B | 162.33 |
| 10x Genomics (TXG) | United States | $1.724B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Schrodinger (SDGR) | United States | $1.553B | 0.00 |
| Azenta (AZTA) | United States | $1.553B | 72.17 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.48 |
| Evolent Health (EVH) | United States | $1.105B | 94.10 |
| Fulgent Genetics (FLGT) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.528B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.453B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.328B | 728.00 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.273B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.218B | 0.00 |
| CapsoVision (CV) | United States | $0.210B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| American Well (AMWL) | United States | $0.129B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.82 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.078B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.042B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |